OptiNose, Inc. (30)

Browse by Contract Category

Contracts

Form of Indemnification Agreement (Filed With SEC on May 12, 2022)
Retention Agreement, dated March 7, 2022, between Michael F. Marino and Optinose US, Inc (Filed With SEC on March 8, 2022)
Underwriting Agreement, dated November 16, 2021, by and between OptiNose, Inc. and Piper Sandler & Co (Filed With SEC on November 18, 2021)
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC (Filed With SEC on November 15, 2021)
Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (Filed With SEC on May 12, 2022)
Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (Filed With SEC on April 26, 2022)
Amended and Restated Employment Agreement, dated March 2, 2022, between OptiNose US, Inc. and Peter K. Miller (Filed With SEC on March 8, 2022)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2022)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2022)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2022)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2022)
Form of Indemnification Agreement (Filed With SEC on March 8, 2022)
Second Amendment to the Note Purchase Agreement, dated November 16, 2021, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on November 16, 2021)
Form of New Warrant (Filed With SEC on November 16, 2021)
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC (Filed With SEC on August 11, 2021)
Renewal and Amendment No. 1, dated February 22, 2021 to Manufacture and Supply Agreement, dated as of August 18, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and... (Filed With SEC on May 5, 2021)
First Amendment to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on March 3, 2021)
Form of Indemnification Agreement (Filed With SEC on March 3, 2021)
Amendment No.1, dated September 15, 2020, to the Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and... (Filed With SEC on November 5, 2020)
Amendment Letter to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on August 18, 2020)
Underwriting Agreement, dated August 13, 2020, by and between Opti (Filed With SEC on August 18, 2020)
Form of Restricted Stock Unit Agreement (Inducement Grant) (Filed With SEC on May 7, 2020)
Note dated April 6, 2020, between OptiNose US, Inc. and JPMorgan Chase Bank, N.A (Filed With SEC on April 16, 2020)
Form of Indemnification Agreement (Filed With SEC on March 5, 2020)
Description of Securities of OptiNose, Inc (Filed With SEC on March 5, 2020)
Underwriting Agreement, dated November 20, 2019, by and between OptiNose, Inc., Jefferies LLC, Cowen and Company, LLC, Piper Jaffray & Co. and the Selling Stockholders named... (Filed With SEC on November 21, 2019)
Common Stock Warrant issued by Optinose, Inc. dated September 12, 2019 (Filed With SEC on September 12, 2019)
Form of Restricted Stock Unit Agreement Under the 2010 Stock Incentive Plan (Filed With SEC on August 12, 2019)
Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and Advance Mold & Manufacturing, Inc. d/b/a Vision... (Filed With SEC on March 6, 2019)
Form of Indemnification Agreement (Filed With SEC on March 6, 2019)